Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.

Bernard H Charbonnel,Hungta Chen,Javier Cid-Ruzafa,Andrew Cooper,Peter Fenici,Marilia B Gomes,Gabriela L Saraiva,Jesús Medina,Antonio Nicolucci,Marina V Shestakova,Iichiro Shimomura,Filip Surmont,Fengming Tang,Jiten Vora,Hirotaka Watada,Kamlesh Khunti

Diabetes, obesity & metabolism（2023）

引用 0|浏览39

暂无评分

摘要

Dual oral therapy was the most common treatment regimen at the start of second-line treatment, and over half of the participants remained on the same treatment during follow-up.

查看译文

关键词

antidiabetic drug,glycaemic control,observational study,second-line treatment,type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要